Jpmorgan Chase & CO Blueprint Medicines Corp Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,222,052 shares of BPMC stock, worth $111 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,222,052

Previous 1,224,654 0.21%

Holding current value

$111 Million

Previous $132 Million 14.4%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$84.1 - $120.5 $218,828 - $313,541	-2,602 Reduced 0.21%	1,222,052 $113 Million
Q2 2024 Aug 12, 2024	SELL	$85.18 - $108.78 $7.39 Million - $9.43 Million	-86,718 Reduced 6.61%	1,224,654 $132 Million
Q1 2024 May 10, 2024	SELL	$73.17 - $99.79 $15.2 Million - $20.8 Million	-208,336 Reduced 13.71%	1,311,372 $124 Million
Q4 2023 Feb 12, 2024	SELL	$43.96 - $92.84 $7.67 Million - $16.2 Million	-174,509 Reduced 10.3%	1,519,708 $140 Million
Q3 2023 Nov 14, 2023	BUY	$46.9 - $66.0 $4.02 Million - $5.65 Million	85,648 Added 5.32%	1,694,217 $85.1 Million
Q2 2023 Aug 11, 2023	BUY	$42.2 - $66.37 $2.4 Million - $3.77 Million	56,813 Added 3.66%	1,608,569 $102 Million
Q1 2023 May 18, 2023	BUY	$37.97 - $50.0 $3.01 Million - $3.96 Million	79,216 Added 5.38%	1,551,756 $69.8 Million
Q1 2023 May 11, 2023	BUY	$37.97 - $50.0 $923,620 - $1.22 Million	24,325 Added 1.68%	1,472,540 $66.2 Million
Q4 2022 Feb 13, 2023	SELL	$41.06 - $66.48 $1.74 Million - $2.82 Million	-42,419 Reduced 2.85%	1,448,215 $63.4 Million
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $11.7 Million - $18.2 Million	-233,856 Reduced 13.56%	1,490,634 $98.2 Million
Q2 2022 Aug 11, 2022	BUY	$45.23 - $70.15 $2.23 Million - $3.46 Million	49,366 Added 2.95%	1,724,490 $87.1 Million
Q1 2022 May 11, 2022	BUY	$54.1 - $110.08 $1.68 Million - $3.41 Million	30,963 Added 1.88%	1,675,124 $107 Million
Q4 2021 Feb 10, 2022	BUY	$94.25 - $115.99 $11.9 Million - $14.7 Million	126,350 Added 8.32%	1,644,161 $176 Million
Q3 2021 Nov 12, 2021	BUY	$80.98 - $109.47 $123 Million - $166 Million	1,517,811 New	1,517,811 $156 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Blueprint Medicines Corp Transaction History